$MBRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in METABASIS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in METABASIS THERAPEUTICS INC. Get notifications about new insider transactions in METABASIS THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2010 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Sell | D | 0.00 | 4,814,725 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
Jan 29 2010 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Sell | D | 0.00 | 4,814,725 | 0 | 0 | 4.8 M to 0 (-100.00 %) |
Jun 25 2009 | MBRX | METABASIS THERAPEU ... | Stoner Elizabeth | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
Jun 25 2009 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
Jun 25 2009 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Director | Option Exercise | A | 0.41 | 5,000 | 2,050 | 5,000 | |
Jun 25 2009 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
Jun 24 2009 | MBRX | METABASIS THERAPEU ... | Schreiner George | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
Jun 24 2009 | MBRX | METABASIS THERAPEU ... | ROHN WILLIAM R | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
Jun 24 2009 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
Jun 24 2009 | MBRX | METABASIS THERAPEU ... | BURGESS DANIEL D | Director | Option Exercise | A | 0.41 | 10,000 | 4,100 | 10,000 | |
Mar 02 2009 | MBRX | METABASIS THERAPEU ... | Nguyen Tran | VP and CFO | Option Exercise | A | 0.35 | 250,000 | 87,500 | 250,000 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 1.00 | 240,000 | 240,000 | 240,000 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 2.10 | 90,000 | 189,000 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 7.55 | 75,000 | 566,250 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | D | 9.03 | 75,000 | 677,250 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Gumbiner Barry | VP Clinical Develop ... | Option Exercise | A | 1.00 | 123,033 | 123,033 | 123,033 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Gumbiner Barry | VP Clinical Develop ... | Option Exercise | D | 2.12 | 5,575 | 11,819 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Gumbiner Barry | VP Clinical Develop ... | Option Exercise | D | 2.46 | 27,875 | 68,573 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Gumbiner Barry | VP Clinical Develop ... | Option Exercise | D | 2.46 | 11,708 | 28,802 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Gumbiner Barry | VP Clinical Develop ... | Option Exercise | D | 7.24 | 27,875 | 201,815 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Gumbiner Barry | VP Clinical Develop ... | Option Exercise | D | 5.85 | 50,000 | 292,500 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | A | 1.00 | 50,565 | 50,565 | 50,565 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | D | 2.00 | 2,150 | 4,300 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | D | 2.46 | 4,515 | 11,107 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | D | 2.46 | 10,750 | 26,445 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | D | 7.35 | 12,900 | 94,815 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | D | 5.72 | 20,250 | 115,830 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | A | 1.00 | 190,321 | 190,321 | 190,321 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | D | 2.10 | 75,000 | 157,500 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | D | 7.55 | 60,000 | 453,000 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | D | 9.03 | 37,300 | 336,819 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | D | 6.88 | 4,368 | 30,052 | 0 | |
Feb 02 2009 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | D | 2.65 | 13,653 | 36,180 | 0 | |
Dec 15 2008 | MBRX | METABASIS THERAPEU ... | Stoner Elizabeth | Director | Option Exercise | A | 0.45 | 10,000 | 4,500 | 10,000 | |
Dec 15 2008 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Executive Off ... | Option Exercise | A | 0.45 | 150,000 | 67,500 | 150,000 | |
Dec 15 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | A | 0.45 | 150,000 | 67,500 | 150,000 | |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.53 | 100 | 53 | 707,220 | 707.1 K to 707.2 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.49 | 100 | 49 | 707,120 | 707 K to 707.1 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.57 | 837 | 477 | 707,020 | 706.2 K to 707 K (+0.12 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.55 | 100 | 55 | 706,183 | 706.1 K to 706.2 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.75 | 963 | 722 | 706,083 | 705.1 K to 706.1 K (+0.14 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.74 | 200 | 148 | 705,120 | 704.9 K to 705.1 K (+0.03 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.70 | 800 | 560 | 704,920 | 704.1 K to 704.9 K (+0.11 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.69 | 500 | 345 | 704,120 | 703.6 K to 704.1 K (+0.07 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.68 | 500 | 340 | 703,620 | 703.1 K to 703.6 K (+0.07 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.67 | 100 | 67 | 703,120 | 703 K to 703.1 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.63 | 400 | 252 | 703,020 | 702.6 K to 703 K (+0.06 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.56 | 100 | 56 | 702,620 | 702.5 K to 702.6 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.59 | 300 | 177 | 702,520 | 702.2 K to 702.5 K (+0.04 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.56 | 500 | 280 | 702,220 | 701.7 K to 702.2 K (+0.07 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.51 | 100 | 51 | 701,720 | 701.6 K to 701.7 K (+0.01 %) |
Nov 19 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Buy | P | 0.49 | 400 | 196 | 701,620 | 701.2 K to 701.6 K (+0.06 %) |
Nov 13 2008 | MBRX | METABASIS THERAPEU ... | Gumbiner Barry | VP Clinical Develop ... | Option Exercise | A | 0.67 | 15,000 | 10,050 | 15,000 | |
Sep 30 2008 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | A | 1.13 | 6,690 | 7,560 | 6,690 | |
Aug 06 2008 | MBRX | METABASIS THERAPEU ... | Millican Trisha | Principal Accountin ... | Option Exercise | A | 1.46 | 29,826 | 43,546 | 29,826 | |
Aug 06 2008 | MBRX | METABASIS THERAPEU ... | Foyt Howard | VP of Clinical Deve ... | Option Exercise | A | 1.46 | 18,568 | 27,109 | 18,568 | |
Aug 06 2008 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | A | 1.46 | 100,000 | 146,000 | 100,000 | |
Aug 06 2008 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Scientific Of ... | Option Exercise | A | 1.46 | 75,000 | 109,500 | 75,000 | |
Jun 12 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | A | 1.79 | 10,000 | 17,900 | 10,000 | |
Jun 11 2008 | MBRX | METABASIS THERAPEU ... | BURGESS DANIEL D | Director | Option Exercise | A | 1.79 | 10,000 | 17,900 | 10,000 | |
Jun 11 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | A | 1.79 | 10,000 | 17,900 | 10,000 | |
Jun 11 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | A | 1.79 | 10,000 | 17,900 | 10,000 | |
Jun 11 2008 | MBRX | METABASIS THERAPEU ... | Schreiner George | Director | Option Exercise | A | 1.79 | 10,000 | 17,900 | 10,000 | |
Jun 11 2008 | MBRX | METABASIS THERAPEU ... | ROHN WILLIAM R | Director | Option Exercise | A | 1.79 | 10,000 | 17,900 | 10,000 | |
Apr 25 2008 | MBRX | METABASIS THERAPEU ... | Stoner Elizabeth | Director | Option Exercise | A | 2.41 | 20,000 | 48,200 | 20,000 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | P | 2.69 | 14,937 | 40,181 | 14,937 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | P | 2.69 | 312,173 | 839,745 | 312,173 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | X | 2.34 | 6,824 | 15,968 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | X | 2.34 | 5,687 | 13,308 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | X | 2.34 | 142,493 | 333,434 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | X | 2.34 | 118,759 | 277,896 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | P | 2.34 | 6,824 | 15,968 | 6,824 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | P | 2.34 | 5,687 | 13,308 | 5,687 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | P | 2.34 | 142,493 | 333,434 | 142,493 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | P | 2.34 | 118,759 | 277,896 | 118,759 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | H | 6.74 | 6,824 | 45,994 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | H | 8.69 | 5,687 | 49,443 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | H | 6.74 | 142,493 | 960,403 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Option Exercise | H | 8.69 | 118,759 | 1,032,491 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Buy | X | 2.34 | 6,824 | 15,968 | 177,970 | 171.1 K to 178 K (+3.99 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Buy | X | 2.34 | 5,687 | 13,308 | 171,146 | 165.5 K to 171.1 K (+3.44 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Buy | X | 2.34 | 142,493 | 333,434 | 3,717,282 | 3.6 M to 3.7 M (+3.99 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Buy | X | 2.34 | 118,759 | 277,896 | 3,574,789 | 3.5 M to 3.6 M (+3.44 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Buy | P | 2.34 | 45,239 | 105,859 | 165,459 | 120.2 K to 165.5 K (+37.63 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | INTERWEST PARTNERS VII L P | 10% Owner | Buy | P | 2.34 | 945,577 | 2,212,650 | 3,456,030 | 2.5 M to 3.5 M (+37.67 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Option Exercise | P | 2.69 | 70,538 | 189,747 | 70,538 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Option Exercise | X | 2.34 | 244,881 | 573,022 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Option Exercise | J | 2.34 | 244,881 | 573,022 | 244,881 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Option Exercise | J | 6.74 | 244,881 | 1,650,498 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Buy | P | 2.34 | 71,866 | 168,166 | 4,814,725 | 4.7 M to 4.8 M (+1.52 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | MPM BIOVENTURES II QP LP | 10% Owner | Buy | X | 2.34 | 244,881 | 573,022 | 4,742,859 | 4.5 M to 4.7 M (+5.44 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | P | 2.69 | 70,538 | 189,747 | 70,538 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | X | 2.34 | 244,881 | 573,022 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | J | 2.34 | 244,881 | 573,022 | 244,881 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | J | 6.74 | 244,881 | 1,650,498 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | P | 2.34 | 71,866 | 168,166 | 4,814,725 | 4.7 M to 4.8 M (+1.52 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Buy | X | 2.34 | 244,881 | 573,022 | 4,742,859 | 4.5 M to 4.7 M (+5.44 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | P | 2.69 | 14,937 | 40,181 | 14,937 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | P | 2.69 | 312,173 | 839,745 | 312,173 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | X | 2.34 | 6,824 | 15,968 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | X | 2.34 | 5,687 | 13,308 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | X | 2.34 | 142,493 | 333,434 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | X | 2.34 | 118,759 | 277,896 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | P | 2.34 | 6,824 | 15,968 | 6,824 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | P | 2.34 | 5,687 | 13,308 | 5,687 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | P | 2.34 | 142,493 | 333,434 | 142,493 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | P | 2.34 | 118,759 | 277,896 | 118,759 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | H | 6.74 | 6,824 | 45,994 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | H | 8.69 | 5,687 | 49,443 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | H | 6.74 | 142,493 | 960,403 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | H | 8.69 | 118,759 | 1,032,491 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Buy | X | 2.34 | 6,824 | 15,968 | 177,970 | 171.1 K to 178 K (+3.99 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Buy | X | 2.34 | 5,687 | 13,308 | 171,146 | 165.5 K to 171.1 K (+3.44 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Buy | P | 2.34 | 45,239 | 105,859 | 165,459 | 120.2 K to 165.5 K (+37.63 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Buy | X | 2.34 | 142,493 | 333,434 | 3,717,282 | 3.6 M to 3.7 M (+3.99 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Buy | X | 2.34 | 118,759 | 277,896 | 3,574,789 | 3.5 M to 3.6 M (+3.44 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Buy | P | 2.34 | 945,577 | 2,212,650 | 3,456,030 | 2.5 M to 3.5 M (+37.67 %) |
Apr 17 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | P | 2.69 | 3,000 | 8,070 | 3,000 | |
Apr 17 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | X | 2.34 | 3,111 | 7,280 | 0 | |
Apr 17 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | P | 2.34 | 3,111 | 7,280 | 3,111 | |
Apr 17 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | H | 8.70 | 3,111 | 27,066 | 0 | |
Apr 17 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Buy | P | 2.34 | 10,000 | 23,400 | 60,337 | 50.3 K to 60.3 K (+19.87 %) |
Apr 17 2008 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Buy | X | 2.34 | 3,111 | 7,280 | 50,337 | 47.2 K to 50.3 K (+6.59 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | CREDIT SUISSE/ | 10% Owner | Option Exercise | A | 2.69 | 82,884 | 222,958 | 82,884 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | CREDIT SUISSE/ | 10% Owner | Option Exercise | D | 2.34 | 119,454 | 279,522 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | CREDIT SUISSE/ | 10% Owner | Option Exercise | A | 2.34 | 119,454 | 279,522 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | CREDIT SUISSE/ | 10% Owner | Option Exercise | D | 6.74 | 119,454 | 805,120 | 0 | |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | CREDIT SUISSE/ | 10% Owner | Buy | O | 0.00 | 119,454 | 0 | 3,863,422 | 3.7 M to 3.9 M (+3.19 %) |
Apr 18 2008 | MBRX | METABASIS THERAPEU ... | CREDIT SUISSE/ | 10% Owner | Buy | P | 2.34 | 196,633 | 460,121 | 3,863,422 | 3.7 M to 3.9 M (+5.36 %) |
Apr 03 2008 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Option Exercise | A | 2.10 | 75,000 | 157,500 | 75,000 | |
Apr 03 2008 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Option Exercise | A | 2.10 | 75,000 | 157,500 | 75,000 | |
Apr 03 2008 | MBRX | METABASIS THERAPEU ... | Erion Mark D | Chief Scientific Of ... | Option Exercise | A | 2.10 | 90,000 | 189,000 | 90,000 | |
Apr 03 2008 | MBRX | METABASIS THERAPEU ... | Foyt Howard | VP of Clinical Deve ... | Option Exercise | A | 2.10 | 40,000 | 84,000 | 40,000 | |
Apr 03 2008 | MBRX | METABASIS THERAPEU ... | Laikind Paul K | Chief Executive Off ... | Option Exercise | A | 2.10 | 180,000 | 378,000 | 180,000 | |
Jun 21 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.08 | 2,611 | 21,097 | 236,234 | 238.8 K to 236.2 K (-1.09 %) |
Jun 21 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.06 | 100 | 806 | 238,845 | 238.9 K to 238.8 K (-0.04 %) |
Jun 21 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.03 | 100 | 803 | 238,945 | 239 K to 238.9 K (-0.04 %) |
Jun 21 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.04 | 100 | 804 | 239,045 | 239.1 K to 239 K (-0.04 %) |
Jun 21 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.05 | 489 | 3,936 | 239,145 | 239.6 K to 239.1 K (-0.20 %) |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | ORONSKY ARNOLD L | Director | Option Exercise | A | 8.04 | 10,000 | 80,400 | 10,000 | |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | Schreiner George | Director | Option Exercise | A | 8.04 | 20,000 | 160,800 | 20,000 | |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | ROHN WILLIAM R | Director | Option Exercise | A | 8.04 | 10,000 | 80,400 | 10,000 | |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | HALE DAVID F | Director | Option Exercise | A | 8.04 | 10,000 | 80,400 | 10,000 | |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | EVNIN LUKE | Director | Option Exercise | A | 8.04 | 10,000 | 80,400 | 10,000 | |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | BURGESS DANIEL D | Director | Option Exercise | A | 8.04 | 10,000 | 80,400 | 10,000 | |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.01 | 400 | 3,204 | 0 | 400 to 0 (-100.00 %) |
Jun 05 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.00 | 9,635 | 77,080 | 400 | 10 K to 400 (-96.01 %) |
May 24 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.00 | 300 | 2,400 | 239,634 | 239.9 K to 239.6 K (-0.13 %) |
Apr 25 2007 | MBRX | METABASIS THERAPEU ... | Beck John W | Chief Financial Off ... | Sell | S | 8.13 | 3,300 | 26,829 | 239,934 | 243.2 K to 239.9 K (-1.36 %) |
Apr 25 2007 | MBRX | METABASIS THERAPEU ... | Baracchini Edgardo Jr | Sr. VP of Business ... | Sell | S | 8.24 | 1,800 | 14,832 | 3,012 | 4.8 K to 3 K (-37.41 %) |